Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study
Authors:
- 20 November 2014
- journal article
- research article
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 41 (5) , 531-538
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute CholangitisGut and Liver, 2013
- THROMBOMODULIN ALFA IN THE TREATMENT OF INFECTIOUS PATIENTS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATIONShock, 2011
- Prognostic Factors and Postoperative Complications in Patients with Colorectal PerforationThe Japanese Journal of Gastroenterological Surgery, 2010
- Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis modelCritical Care, 2009
- Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin ComplexesArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trialJournal of Thrombosis and Haemostasis, 2006
- The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanismJournal of Clinical Investigation, 2005
- Thrombomodulin-Protein C-EPCR SystemArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsisCritical Care Medicine, 1983
- Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, , and C1 esteraseBiochimica et Biophysica Acta (BBA) - Enzymology, 1977